The aim of the present study was to assess the autoregulatory capacity of renal blood flow (RBF) and of the pressure-natriuresis characteristics in the early phase of heart failure (HF) in rats, normotensive and with angiotensin II (ANG II)-dependent hypertension. Ren-2 transgenic rats (TGR) were employed as a model of ANG II-dependent hypertension. HF was induced by creating the aorto-caval fistula (ACF). One week after ACF creation or sham-operation, the animals were prepared for studies evaluating in vivo RBF autoregulatory capacity and the pressure-natriuresis characteristics after stepwise changes in renal arterial pressure (RAP) induced by aortic clamping. In ACF TGR the basal mean arterial pressure, RBF, urine flow (UF), and absolute sodium excretion (UNaV) were all significantly lower tha n in sham-operated TGR. In the latter, reductions in renal arterial pressure (RAP) significantly decreased RBF whereas in ACF TGR they did not change. Stepwise reductions in RAP resulted in marked decreases in UF and UNaV in sham-operated as well as in ACF TGR, however, these decreases were significantly greater in the former. Our data show that compared with sham-operated TGR, ACF TGR displayed well-maintained RBF autoregulatory capacity and improved slope of the pressure-natriuresis relationship. Thus, even though in the very early HF stage renal dysfunction was demonstrable, in the HF model of ANG II-dependent hypertensive rat such dysfunction and the subsequent HF decompensation cannot be simply ascribed to impaired renal autoregulation and pressure-natriuresis relationship.

Center for Experimental Medicine Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Internal Medicine 1 Cardiology University Hospital Olomouc and Palacký University Olomouc Czech Republic

Department of Pathology 3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Pathophysiology 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Renal and Body Fluid Physiology Mossakowski Medical Research Institute Polish Academy of Sciences Warsaw Poland

Komentář v

Hypertens Res. 2024 Apr;47(4):1081-1083. doi: 10.1038/s41440-023-01512-7. PubMed

Zobrazit více v PubMed

Roger VL. Epidemiology of heart failure. A contemporary perspective. Circ Res. 2021;128:1421–34. doi: 10.1161/CIRCRESAHA.121.318172. PubMed DOI

Bullock H, Yellon DM, Hausenloy DJ. Reducing myocardial infarct size: challenges and future opportunities. Heart. 2016;102:341–8. doi: 10.1136/heartjnl-2015-307855. PubMed DOI PMC

Mullens W, Verbrugge FH, Nijst P, Tang WHW. Renal sodium avidity in heart failure: from pathophysiology to treatment strategies. Eur Heart J. 2017;38:1872–82. doi: 10.1093/eurheartj/ehx035. PubMed DOI

Kassi M, Hannawi B, Trachtenberg B. Recent advances in heart failure. Curr Opin Cardiol. 2018;33:249–56. doi: 10.1097/HCO.0000000000000497. PubMed DOI

Rangawwami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. American Heart Asssociation Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies. A scientific statement from the American Heart Association. Circulation. 2019;139:e840–78. PubMed

Mullens W, Damman K, Testani JM, Martens P, Mueller C, Lassus J, et al. Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22:584–603. doi: 10.1002/ejhf.1697. PubMed DOI

Khayyat-Kholghi M, Oparil S, Davis BR, Tereshchenko LG. Worsening kidney function is the major mechanism of heart failure in hypertension. The ALLHAT study. J Am Coll Cardiol HF. 2021;9:100–111. PubMed PMC

Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJV, Yusuf S, et al. Renal function as a predictor of outcome in broad spectrum of patients with heart failure. Circulation. 2006;113:671–8. doi: 10.1161/CIRCULATIONAHA.105.580506. PubMed DOI

Packer M, Lee WH, Kessler PD. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. Circulation. 1986;74:766–74. doi: 10.1161/01.CIR.74.4.766. PubMed DOI

Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102:203–10. doi: 10.1161/01.CIR.102.2.203. PubMed DOI

Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006;17:2886–91. doi: 10.1681/ASN.2006010063. PubMed DOI

Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248–54. doi: 10.1016/0735-1097(92)90167-L. PubMed DOI

Mann DL, Felker M. Mechanisms and models in heart failure. A translation approach. Circ Res. 2021;128:1435–50. doi: 10.1161/CIRCRESAHA.121.318158. PubMed DOI PMC

Vallon V, Verma S. Effects of SGLT2 inhibitors on kidney and cardiovascular function. Annu Rev Physiol. 2021;83:503–28. doi: 10.1146/annurev-physiol-031620-095920. PubMed DOI PMC

Barger AC, Muldowney FP, Liebowitz MR. Role of the kidney in the pathogenesis of congestive heart failure. Circulation. 1959;20:273–85. doi: 10.1161/01.CIR.20.2.273. PubMed DOI

Hostetter TH, Pfeffer JM, Pfeffer MA, Dworkin LD, Braunwald E, Brenner BM. Cardiorenal hemodynamics and sodium excretion in rats with myocardial infarction. Am J Physiol. 1983;245:H98–103. PubMed

Ichikawa I, Pfeffer JM, Pfeffer MA, Hostetter TH, Brenner BM. Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res. 1984;55:669–675. doi: 10.1161/01.RES.55.5.669. PubMed DOI

Stanton RC, Brenner BM. Role of kidney in congestive heart failure. Acta Med Scand. 1986;707:21–5. doi: 10.1111/j.0954-6820.1986.tb18110.x. PubMed DOI

Numabe A, Hishikimi T, Komatsu K, Frohlich ED. Intrarenal hemodynamics in low- and high-output cardiac failure in rats. Am J Med Sci. 1994;308:331–7. doi: 10.1097/00000441-199412000-00004. PubMed DOI

Nishikimi T, Frohlich ED. Glomerular hemodynamics in aortocaval fistula rats: role of renin-angiotensin system. Am J Physiol. 1993;264:R681–86. PubMed

Vacková Š, Kikerlová S, Melenovský V, Kolář F, Imig JD, Kompanovska-Jezierska E, et al. Altered renal vascular responsiveness in rats with angiotensin II-dependent hypertension and congestive heart failure. Kidney Blood Press Res. 2019;44:792–809. doi: 10.1159/000501688. PubMed DOI PMC

Honetschlagerová Z, Škaroupková P, Kikerlová S, Vaňourková Z, Husková Z, Melenovský V, et al. Renal sympathetic denervation attenuates congestive heart failure in angiotensin II-dependent hypertension: studies with Ren-2 transgenic hypertensive rats with aorto-caval fistula. Kidney Blood Press Res. 2021;46:95–113. doi: 10.1159/000513071. PubMed DOI

Kratky V, Vanourkova Z, Sykora M, Szeiffova Bacova B, Hruskova Z, Kikerlova S, et al. AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats. Sci Rep. 2021;11:4271. doi: 10.1038/s41598-021-83906-6. PubMed DOI PMC

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DC. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J Pharm Pharmacother. 2010;2:94–9. doi: 10.4103/0976-500X.72351. PubMed DOI PMC

Červenka L, Melenovský V, Husková Z, Škaroupková P, Nishiyama A, Sadowski J. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula. Clin Exp Pharm Physiol. 2015;42:795–807. doi: 10.1111/1440-1681.12419. PubMed DOI

Honetschlagerová Z, Škaroupková P, Kikerlová S, Husková Z, Maxová H, Melenovský V, et al. Effects of renal sympathetic denervation on the course of congestive heart failure combined with chronic kidney disease: insight from studies with fawn-hooded hypertensive rats with volume overload induced using aorto-caval fistula. Clin Exp Hypertens. 2021;43:522–535. doi: 10.1080/10641963.2021.1907398. PubMed DOI

Winaver J, Hoffman A, Burnett JC, Jr, Haramati A. Hormonal determinants of sodium excretion in rats with experimental high-output heart failure. Am J Physiol. 1988;254:R776–84. PubMed

Abassi Z, Goltsman I, Karram T, Winaver J, Hoffman A. Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy. J Biomed Biotechnol. 2011;2011:729497. doi: 10.1155/2011/729497. PubMed DOI PMC

Kratky V, Kopkan L, Kikerlova S, Huskova Z, Taborsky M, Sadowski J, et al. The role of renal vascular reactivity in the development of renal dysfunction in compensated and decompensated congestive heart failure. Kidney Blood Press Res. 2018;43:1730–41. doi: 10.1159/000495391. PubMed DOI

Melenovsky V, Skaroupkova P, Benes J, Torresova V, Kopkan L, Cervenka L. The course of heart failure development and mortality in rats with volume overload due to aorto-caval fistula. Kidney Blood Press Res. 2012;35:167–73. doi: 10.1159/000331562. PubMed DOI

Červenka L, Wang C-T, Navar LG. Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats. Am J Physiol. 1998;274:F940–5. PubMed

Husková Z, Kramer HJ, Vaňourková Z, Červenka L. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats. J Hypertens. 2006;24:517–27. doi: 10.1097/01.hjh.0000209988.51606.c7. PubMed DOI

Kopkan L, Kramer HJ, Huskova Z, Vaňourková Z, Škaroupková P, Thumová M, et al. The role of intrarenal angiotensin II in the development of hypertension in Ren-2 transgenic rats. J Hypertens. 2005;23:1531–9. doi: 10.1097/01.hjh.0000174972.46663.5e. PubMed DOI

Kopkan L, Husková Z, Vanourková Z, Thumová M, Skaroupková P, Cervenka L, et al. Superoxide and its interaction with nitric oxide modulates renal function in prehypertensive Ren-2 transgenic rats. J Hypertens. 2007;25:2257–65. doi: 10.1097/HJH.0b013e3282efb195. PubMed DOI

Jíchová Š, Kopkan L, Husková Z, Doleželová Š, Neckář J, Kujal P, et al. Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats. J Hypertens. 2016;34:2008–25. doi: 10.1097/HJH.0000000000001029. PubMed DOI PMC

Roman RJ, Cowley AW., Jr Characterization of a new model for the study of pressure-natriuresis in the rat. Am J Physiol. 1985;248:F190–8. PubMed

Wang CT, Chin SY, Navar LG. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol. 2000;279:F319–25. PubMed

Erbanová M, Thumová M, Husková Z, Vaněčková I, Vaňourková Z, Mullins JJ, et al. Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats. J Hypertens. 2009;27:575–86. doi: 10.1097/HJH.0b013e32831cbd5a. PubMed DOI

Sporková A, Kopkan L, Vacarbová Š, Husková Z, Hwang SH, Hammock BD, et al. Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure 2-kidney, 1-clip hypertensive rats. Am J Physiol. 2011;300:R1468–75. PubMed PMC

Honetschlagerová Z, Sporková A, Kopkan L, Husková Z, Hwang SH, Hammock BD, et al. Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats. J Hypertens. 2011;29:1590–601. doi: 10.1097/HJH.0b013e328349062f. PubMed DOI PMC

Varcabová Š, Husková Z, Kramer HJ, Hwang HS, Hammock BD, Imig JD, et al. Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system. Clin Exp Pharm Physiol. 2013;40:273–81. doi: 10.1111/1440-1681.12018. PubMed DOI PMC

Honetschlagerová Z, Kitada K, Husková Z, Sporková A, Kopkan L, Bürgelová M, et al. Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME. J Hypertens. 2013;31:321–32. doi: 10.1097/HJH.0b013e32835b50aa. PubMed DOI PMC

Pokorný M, Mrázová I, Šochman J, Melenovský V, Malý J, Pirk J, et al. Isovolumic loading of the failing heart by intraventricular placement of a spring expander attenuates cardiac atrophy after heterotopic heart transplantation. Biosci Rep. 2018;38:BSR20180371. doi: 10.1042/BSR20180371. PubMed DOI PMC

Kala P, Vaňourková Z, Škaroupková P, Kompanowska-Jezierska E, Sadowski J, Walkowska A, et al. Endothelin type A receptor blockade increases renoprotection in congestive heart failure combined with chronic kidney disease: studies in 5/6 nephrectomized rats with aorto-caval fistula. Biomed Pharmacother. 2023;158:114157. doi: 10.1016/j.biopha.2022.114157. PubMed DOI

Gawrys O, Husková Z, Škaroupková P, Honetschlägerová Z, Vaňourková Z, Kikerlová S, et al. The treatment with sGC stimulator improves survival of hypertensive rats in response to volume-overload induced by aorto-caval fistula [published online ahead of print, 2023 Jun 20]. Naunyn Schmiedebergs Arch Pharmacol. 2023; 10.1007/s00210-023-02561-y. PubMed PMC

Obayashi M, Yano M, Kohno M, Kobayashi S, Tanigawa T, Hironaka K, et al. Dose-dependent effect of ANG II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophy. Am J Physiol. 1997;273:H1824–31. PubMed

Nakano Y, Hirano T, Uehara K, Nishibayashi S, Hattori K, Aihara M, et al. New rat model induced by anti-glomerular basement membrane antibody shows severe glomerular adhesion in early stage and quickly progresses to end-stage renal failure. Pathol Int. 2008;58:361–70. doi: 10.1111/j.1440-1827.2008.02237.x. PubMed DOI

Gerdes AM, Clark LC, Capassso JM. Regression of cardiac hypertrophy after closing and aorto-caval fistula in rats. Am J Physiol. 1995;37:H2345–351. PubMed

Brower GL, Henegar JR, Janicki JS. Temporal evaluation of left ventricular remodeling and function in rats with chronic volume overload. Am J Physiol. 1996;271:H2071–8. PubMed

Brower GL, Janicki JS. Contribution of ventricular remodeling to pathogenesis of heart failure in rats. Am J Physiol. 2001;280:H674–83. PubMed

Wang X, Ren B, Liu S, Sentex E, Tappia PS, Dhalla NS. Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat. J Appl Physiol. 2003;94:752–63. doi: 10.1152/japplphysiol.00248.2002. PubMed DOI

Oliver-Dussault C, Ascah A, Marcil M, Matas J, Picard S, Pibarot B, et al. Early predictors of cardiac decompensation in experimental volume overload. Mol Cell Biochem. 2010;338:271–81. doi: 10.1007/s11010-009-0361-5. PubMed DOI

Hutchinson KR, Guggilam A, Cismowski MJ, Galantowics ML, West TA, Stewart JA, et al. Temporal pattern of left ventricle structural and functional remodeling following reversal of volume overload heart failure. J Appl Physiol. 2011;111:1778–88. doi: 10.1152/japplphysiol.00691.2011. PubMed DOI PMC

Kala P, Miklovič M, Jíchová Š, Škaroupková P, Vaňourková Z, Maxová H, et al. Effects of Epoxyeicosatrienoic acid-enhancing therapy on the course of congestive heart failure in angiotensin II-dependent rat hypertension: from mRNA analysis towards functional in vivo evaluation. Biomedicines. 2021;9:1053. doi: 10.3390/biomedicines9081053. PubMed DOI PMC

Kala P, Červenka L, Škaroupková P, Táborský M, Kompanowska-Jezierska E, Sadowski J. Sex-linked differences in the mortality in Ren-2 transgenic hypertensive rats with aorto-caval fistula: effects of treatment with angiotensin converting enzyme alone and combined with inhibitor of soluble epoxide hydrolase. Physiol Res. 2019;68:589–601. doi: 10.33549/physiolres.934094. PubMed DOI

Krátký V, Kikerlová S, Husková Z, Sadowski J, Kolář F, Červenka L. Enhanced renal vascular responsiveness to angiotensin II and norepinephrine: a unique feature of female rats with congestive heart failure. Kidney Blood Press Res. 2019;44:1128–41. doi: 10.1159/000502379. PubMed DOI

Benes J, Jr, Melenovsky V, Skaroupkova P, Pospisilova J, Petrak J, Cervenka L, et al. Myocardial morphological characteristics and proarrhythmic substrate in the rat model of heart failure due to chronic volume overload. Anat Rec (Hoboken) 2011;294:102–11. doi: 10.1002/ar.21280. PubMed DOI

Du Y, Plante E, Janicki JS, Brower GL. Temporal evaluation of cardiac myocyte hypertrophy and hyperplasia in male rats secondary to chronic volume overload. Am J Pathol. 2010;177:1155–63. doi: 10.2353/ajpath.2010.090587. PubMed DOI PMC

Linzbach AJ. Heart failure from the point of view of quantitative anatomy. Am J Cardiol. 1960;5:370–82. doi: 10.1016/0002-9149(60)90084-9. PubMed DOI

Goldberg A, Hammerman H, Petcherski S, Zdorovyak A, Yalonetsky S, Kapeliovich M, et al. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J. 2005;150:330–7. doi: 10.1016/j.ahj.2004.09.055. PubMed DOI

Rangawwami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. American Heart Asssociation Council on the Kidney in cardiovascular disease and council on clinical cardiology. Circulation. 2019;139:e840–78. PubMed

Ciccarelli M, Dawson D, Facao-Pires I, Giacca M, Hamdani N, Heymans S, et al. Reciprocal organ interactions during heart failure: a position paper from the ESC Working Group on Myocardial Function. Cardiovasc Res. 2021;117:2416–33. doi: 10.1093/cvr/cvab009. PubMed DOI PMC

Carlstrom M, Wilcox CS, Arendshorst WJ. Renal autoregulation in health and disease. Physiol Rev. 2015;95:405–11. doi: 10.1152/physrev.00042.2012. PubMed DOI PMC

Roman RJ, Cowley AW., Jr Abnormal pressure-diuresis-natriuresis response in spontaneously hypertensive rats. Am J Physiol. 1985;248:F199–205. PubMed

Roman RJ. Abnormal renal hemodynamics and pressure-natriuresis relationship in Dahl salt-sensitive rats. Am J Physiol. 1986;251:F57–65. PubMed

Miao CY, Liu KL, Benzoni D, Sassard J. Acute pressure-natriuresis function shows early impairment in Lyon hypertensive rats. J Hypertens. 2005;23:1225–31. doi: 10.1097/01.hjh.0000170386.84450.e3. PubMed DOI

Ploth DW, Roy RN, Huang WC, Navar LG. Impaired renal blood flow and cortical pressure autoregulation in contralateral kidneys of Goldblatt hypertensive rats. Hypertension. 1981;3:67–74. doi: 10.1161/01.HYP.3.1.67. PubMed DOI

Van der Mark J, Kline RL. Altered pressure natriuresis in chronic angiotensin II hypertension in rats. Am J Physiol. 1994;266:F739–48. PubMed

Mitchell KD, Navar LG. Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis and management. New York, NY, Raven Press, Publishers, 1990; pp. 1437–1452.

Hall JE, Brans MV, Henegar JR. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol. 1999;10:S258–65. PubMed

Kantachuvesiri S, Fleming S, Peters J, Peters B, Brooker G, Lammie AG, et al. Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J Biol Chem. 2001;276:36727–33. doi: 10.1074/jbc.M103296200. PubMed DOI

Vaňourková Z, Kramer HJ, Husková Z, Vaněčkováková I, Opočenský M, Čertíková Chábová V, et al. AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage Cyp1a1-Ren-2 transgenic rats with inducible hypertension. J Hypertens. 2006;24:2465–72. doi: 10.1097/01.hjh.0000251909.00923.22. PubMed DOI

Mitchell KD, Bagatell SJ, Miller CS, Mouton CR, Seth DM, Mullins JJ. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal II levels of graded severity in Cyp1a1-Ren2 transgenic rats. JRAAS. 2006;7:74–86. PubMed

Guyton AC, Hall JE, Coleman TG, Manning RD Jr. The dominant role of the kidneys in the long term regulation of arterial pressure in normal and hypertensive states. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis and management. New York, NY, Raven Press, Publishers, 1990; pp. 1029–1052.

Lippoldt A, Gross V, Bohlender J, Ganten U, Luft FC. Lifelong angiotensin-converting enzyme inhibition, pressure natriuresis, and renin-angiotensin system gene expression in transgenic (mRen-2)27 rats. J Am Soc Nephrol. 1996;7:2119–29. doi: 10.1681/ASN.V7102119. PubMed DOI

Springate J, Van Liew J, Ganten D. Enalapril and pressure-diuresis in hypertensive rats transgenic for mouse renin gene. Kidney Blood Press Res. 1997;20:1–5. doi: 10.1159/000174116. PubMed DOI

Hall JE, Mizelle HL, brands MV, Hildenbrandt DA. Pressure natriuresis and angiotensin II in reduced kidney mass, salt-induced hypertension. Am J Physiol. 1992;262:R62–71. PubMed

Fox J, Guan S, Hymel AA, Navar LG. Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats. Am J Physiol. 1992;262:F902–9. PubMed

Husková Z, Kramer HJ, Thumová M, Vanourková Z, Bürgelová M, Teplan V, et al. Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats. Kidney Blood Press Res. 2006;29:74–83. doi: 10.1159/000092981. PubMed DOI

Kala P, Gawrys O, Miklovič M, Vaňourková Z, Škaroupková P, Jíchová Š, et al. Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension. J Hypertens. 2023;41:99–114. doi: 10.1097/HJH.0000000000003307. PubMed DOI PMC

Renal sympathetic denervation improves pressure-natriuresis relationship in cardiorenal syndrome: insight from studies with Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula